Dr. Michael Keller, MD
Claim this profileChildren's National Hospital
Studies Primary Immunodeficiency
Studies Coronavirus
4 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Michael Keller, MD is currently running
T Cell Therapy
for COVID-19
This is an open label, phase I dose-escalation study to evaluate the safety of coronavirus-specific T cell (CST) therapy for prevention of SARS-CoV-2 infection in immunocompromised patients following hematopoietic stem cell transplantation (HSCT). Participants will receive donor-derived CSTs for prevention of SARS-CoV-2 infection after HSCT (≥28 days and \<4 months after HSCT). In this dose escalation trial, three doses (1x107/m2, 2x107/m2, and 4x107/m2) will be tested for safety, with study arms for adult (≥18 years of age and \<80 years) HSCT recipients (Arm A) and pediatric (≥12 years of age and \<18 years) HSCT recipients (Arm B), and defined dose escalations in each study arm. The study agent will be assessed for safety (stopping rules defined) and antiviral activity.
Recruiting1 award Phase 123 criteria
NST Therapy
for Chronic Norovirus in Immunocompromised Patients
This is a Phase I dose-escalation study to evaluate the safety of norovirus -specific T-cell (NST) therapy for chronic norovirus infection in participants following hematopoietic stem cell transplantation (HSCT) or with primary immunodeficiency disorders (PID) who have not undergone HSCT.
Recruiting1 award Phase 15 criteria
More about Michael Keller, MD
Clinical Trial Related7 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Michael Keller, MD has experience with
- Coronavirus-specific T Cell (CST)
- Centralized Sequencing Protocol
- Norovirus-specific T-cell (NST) Therapy
- Elapegademase-lvlr
Breakdown of trials Michael Keller, MD has run
Primary Immunodeficiency
Coronavirus
Skin and Soft Tissue Infections
Infections and Infestations
COVID-19
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Keller, MD specialize in?
Michael Keller, MD focuses on Primary Immunodeficiency and Coronavirus. In particular, much of their work with Primary Immunodeficiency has involved treating patients, or patients who are undergoing treatment.
Is Michael Keller, MD currently recruiting for clinical trials?
Yes, Michael Keller, MD is currently recruiting for 2 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Michael Keller, MD has studied deeply?
Yes, Michael Keller, MD has studied treatments such as Coronavirus-specific T cell (CST), Centralized Sequencing Protocol, Norovirus-specific T-cell (NST) therapy.
What is the best way to schedule an appointment with Michael Keller, MD?
Apply for one of the trials that Michael Keller, MD is conducting.
What is the office address of Michael Keller, MD?
The office of Michael Keller, MD is located at: Children's National Hospital, Washington, District of Columbia 20010 United States. This is the address for their practice at the Children's National Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.